[New world-wide therapy standard determined by German Study Group. Decisive progress in ovarian carcinoma].
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D016190:Carboplatin / Q000008:administration & dosage / Q000009:adverse effects; D002945:Cisplatin / Q000008:administration & dosage / Q000009:adverse effects; D019091:Critical Pathways / Q000592:standards*; D005260:Female; D006801:Humans; D010051:Ovarian Neoplasms / Q000188:drug therapy / Q000401:mortality / Q000451:nursing*; D017239:Paclitaxel / Q000008:administration & dosage; D011788:Quality of Life; D012955:Societies, Medical; D015996:Survival Rate; D016896:Treatment Outcome
D016190:Carboplatin; D017239:Paclitaxel; D002945:Cisplatin